ACE2 and COVID-19: The ACE2 levels are elevated by several factors (such as sex and age), and comorbidities such as cardiovascular diseases, obesity, and diabetes [14], which are known risk factors of the worse clinical manifestations observed in COVID-19 patients [15,16].